Left Ventricular Assist Device, Implantable Cardioverter Defibrillator, and Radiation Therapy: A Technical Report,

Alexander Bennassi1, Tony Truong2, Nhu Hanh To1

  • 1Department of Radiation Oncology And Henri Mondor Breast Center, Hôpital Henri Mondor, Créteil, France; Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, i-Biot and University of Paris East Créteil (UPEC), France.

PubMed

Insights

Managing patients with both implantable cardioverter defibrillators (ICDs) and left ventricular assist devices (LVADs) during radiation therapy (RT) requires careful planning. This case report details considerations for safe RT delivery in patients with advanced cardiac devices.

Area of Science:

  • Cardiology
  • Radiation Oncology
  • Medical Physics

Background:

  • Cardiology advancements have improved survival for patients with severe heart conditions requiring implantable cardioverter defibrillators (ICDs) and left ventricular assist devices (LVADs).
  • Radiation therapy (RT) is a critical cancer treatment, but its delivery poses challenges for patients with cardiac devices.
  • Managing patients with both ICDs and LVADs during RT requires addressing potential device malfunctions and radiation interactions.

Purpose of the Study:

  • To present a case of a patient with both a triple-chamber ICD and an electronically equipped LVAD undergoing RT.
  • To explore dosimetric considerations and device interactions during RT for patients with advanced cardiac devices.
  • To provide recommendations for the safe and effective integration of RT in this patient population.

Main Methods:

  • Case report of a patient with a triple-chamber ICD and an electronically equipped LVAD undergoing RT.
  • Analysis of dosimetric considerations and potential device interactions.
  • Development of adapted simulations to minimize risks associated with RT delivery.

Main Results:

  • The study highlights the unique challenges in managing patients with combined ICD and LVAD devices during RT.
  • Identified specific risks related to radiation exposure and device function.
  • Demonstrated the necessity of adapted simulations and careful planning for RT delivery.

Conclusions:

  • Safe and effective RT delivery is achievable in patients with advanced cardiac devices like ICDs and LVADs.
  • Careful consideration of dosimetric factors, device interactions, and adapted simulations is crucial.
  • This work bridges a knowledge gap, offering recommendations for managing these complex cases.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
38
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
36
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
222
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
41
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
29